Skip to main navigation Skip to search Skip to main content

A dual role of RBM42 in modulating splicing and translation of CDKN1A/p21 during DNA damage response

  • Bella M. Ben-Oz
  • , Feras E. Machour
  • , Marian Nicola
  • , Amir Argoetti
  • , Galia Polyak
  • , Rawad Hanna
  • , Oded Kleifeld
  • , Yael Mandel-Gutfreund
  • , Nabieh Ayoub

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

p53-mediated cell cycle arrest during DNA damage is dependent on the induction of p21 protein, encoded by the CDKN1A gene. p21 inhibits cyclin-dependent kinases required for cell cycle progression to guarantee accurate repair of DNA lesions. Hence, fine-tuning of p21 levels is crucial to preserve genomic stability. Currently, the multilayered regulation of p21 levels during DNA damage is not fully understood. Herein, we identify the human RNA binding motif protein 42 (RBM42) as a regulator of p21 levels during DNA damage. Genome-wide transcriptome and interactome analysis reveals that RBM42 alters the expression of p53-regulated genes during DNA damage. Specifically, we demonstrate that RBM42 facilitates CDKN1A splicing by counteracting the splicing inhibitory effect of RBM4 protein. Unexpectedly, we also show that RBM42, underpins translation of various splicing targets, including CDKN1A. Concordantly, transcriptome-wide mapping of RBM42-RNA interactions using eCLIP further substantiates the dual function of RBM42 in regulating splicing and translation of its target genes, including CDKN1A. Collectively, our data show that RBM42 couples splicing and translation machineries to fine-tune gene expression during DNA damage response.
Original languageEnglish
Article number7628
Pages (from-to)1-18
Number of pages18
JournalNature Communications
Volume14
Early online date22 Nov 2023
DOIs
Publication statusPublished - 2023
Externally publishedYes

Funding

We are grateful to Yoav Arava, Ofri Levi and Ayala Shiber for their help in designing and analyzing the polysome profiling experiment and for providing necessary materials. We thank Varada Liveanu for helping in the bacterial purification of human RBM42 protein. We thank David Meiri’s Lab for providing us the BioVision, 1006-200 kit used for the Annexin V-FITS experiment. We thank Tamar Lahav for her help in eCLIP data release. We thank Enas Abu-Zhayia, Alma-Sophia Barisaac, and Inna Pigalchock for helping setup the minigene splicing reporter assay. We thank bioRENDER (biorender.com) for assisting in drawing the model and the schematics presented in the figures. Research in the Ayoub lab is supported by grants from the Israel Science Foundation (2511/19), ISF-NSFC fund (# 2511/18), Israel Cancer Association (20200080). B.M.B.-O. is supported by TICC fellowship. F.E.M. is supported by Irwin and Joan Jacob and Clore fellowship. M.N. is supported by the VATAT fellowship for outstanding minority MSc students. YMG research is supported by the Israel Science Foundation (1556/22). R.H is supported by the Neubauer Family foundation. OK research is supported by grants from the Israel Science Foundation (1623/17 and 2167/17). N.A. is supported by the Neubauer Family foundation.

FundersFunder number
ISF-NSFC fund2511/18
TICC1556/22
Neubauer Family Foundation1623/17, 2167/17
Israel Cancer Association20200080
Israel Science Foundation2511/19

    Fingerprint

    Dive into the research topics of 'A dual role of RBM42 in modulating splicing and translation of CDKN1A/p21 during DNA damage response'. Together they form a unique fingerprint.

    Cite this